Pfizer Consumer Chief Sees Chronic Conditions In OTC Future
This article was originally published in The Pink Sheet Daily
Executive Summary
The Pfizer exec's switch expectations align with FDA drug center chief Janet Woodcock's recent comments that nonprescription treatments for conditions including high cholesterol, hypertension, diabetes and obesity would benefit the public health.